Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × TroVax × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 6 Gynecologic 1 Gastrointestinal 1

Conditions

Recurrence 1 Ovarian Neoplasms 1 Fallopian Tube Neoplasms 1

Interventions

Paclitaxel 261 Carboplatin 244 Cisplatin 152 Bevacizumab 102 Gemcitabine 78 Topotecan 77 liposomal doxorubicin 67 pembrolizumab 56 Docetaxel 55 Cyclophosphamide 50 Taxes 48 Radiotherapy 44 Surveys and Questionnaires 43 Doxorubicin 43 Filgrastim 42 olaparib 41 Brachytherapy 37 Drug Therapy 31 Blood Specimen Collection 28 niraparib 27 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 26 human papillomavirus vaccine, L1 type 16, 18 24 Peripheral Blood Stem Cell Transplantation 23 Oxaliplatin 22 atezolizumab 21 Pemetrexed 21 Nivolumab 21 Hyperthermic Intraperitoneal Chemotherapy 21 Etoposide 21 Immunoglobulin G 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01556841 2019-05-09

TRIOC

University College, London

Phase 2 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡